BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Europabio
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260713T100000
DTEND;TZID=Europe/Brussels:20260713T110000
DTSTAMP:20260726T232931
CREATED:20260615T074916Z
LAST-MODIFIED:20260703T110803Z
UID:9672-1783936800-1783940400@www.europabio.org
SUMMARY:EFIB Den Haag Statement - A modernised European Union for Industrial Biotechnology
DESCRIPTION:EuropaBio’s EFIB Statement presents three clear asks for the European Union: \n\n\n\nAsk 1 – Modernising regulation and policy: A dedicated\, horizontal EU Regulation for Microorganisms \n\n\n\nAsk 2 – Education and awareness: Future-looking stakeholder engagement and Representation \n\n\n\nAsk 3 – Financing innovation: Delivering a mature funding and collaborative framework \n\n\n\nThese asks sit within a progressive legislative mandate for industrial biotechnology and microorganisms. It supports the translation of a competitiveness agenda into legislation that delivers the bioeconomy. \n\n\n\nJoin EuropaBio for a deep dive into the EFIB Statement and what it means for innovation and manufacturing in the European Union? \n\n\n\nAGENDA \n\n\n\nPresentation of the EFIB statement: Claire Skentelbery\, Director General\, EuropaBio \n\n\n\nFireside chat: Giovanni Colombo\, Group Senior Director Public Affairs\, dsm-firmenich and Board Member EuropaBio \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/efib-den-haag-statement-a-modernised-european-union-for-industrial-biotechnology/
CATEGORIES:EFIB,EuropaBio,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/06/EFIB-2026-Den-Haag-Statement-Event-Banner-Website-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260701T093000
DTEND;TZID=Europe/Brussels:20260701T133000
DTSTAMP:20260726T232931
CREATED:20260505T073147Z
LAST-MODIFIED:20260519T114509Z
UID:9589-1782898200-1782912600@www.europabio.org
SUMMARY:EuropaBio Biomanufacturing Policy Summit 2026
DESCRIPTION:From legislation to impact for Europe \n\n\n\nBiomanufacturing lies at the heart of Europe’s future societal and entrepreneurial strength and is changing the business landscape for both emerging innovators and established industry champions. \n\n\n\nEuropaBio’s 4th Biomanufacturing Policy Summit will focus on how legislation delivers impact within a proactive Biomanufacturing strategy\, and how we establish EU targets for outcomes. It will also showcase the 2026 update of the EuropaBio WIfoR study ‘Measuring the Economic Footprint of the Biotechnology Industry in the European Union’ prior to full report launch in September. \n\n\n\nThe prize is globally competitive multi-sector biomanufacturing\, keeping pace with industrial transition in major global regions and securing Europe’s supply chains\, healthcare future\, decarbonisation and economic resilience. \n\n\n\nThis meeting will bring together EuropaBio Members\, representatives of key sectors\, plus national and EU stakeholders across institutions. \n\n\n\nThis event will be accessible by invitation only\, for more information contact us at: communications@europabio.org and c.skentelbery@europabio.org
URL:https://www.europabio.org/event/europabio-biomanufacturing-policy-summit-2026/
CATEGORIES:Biomanufacturing Platform,EuropaBio,Healthcare Biotech,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/05/Event-Banner-EuropaBio-Biomanufacturing-Policy-Summit-2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260625T130000
DTEND;TZID=Europe/Brussels:20260625T140000
DTSTAMP:20260726T232931
CREATED:20260622T132337Z
LAST-MODIFIED:20260622T132339Z
UID:9699-1782392400-1782396000@www.europabio.org
SUMMARY:Preparing for scale: industrial readiness and infrastructure access
DESCRIPTION:APROVALS Webinar Series – Public Session \n\n\n\nThis is the first session of the APROVALS public webinar series\, a programme of collective learning events open to companies participating in the project and to the broader industrial ecosystem. \n\n\n\nAPROVALS webinars are designed to go beyond individual sandbox sessions: they create a shared space where companies can compare experiences\, discuss cross-cutting challenges\, and engage with external experts on the topics that matter most to scaling innovative technologies. \n\n\n\nSession #1 – Preparing for scale: industrial readiness and infrastructure access \n\n\n\nOne of the most strategic — and most frequently asked — questions among APROVALS participants: how do you know when you are ready to move from pilot to industrial scale? \n\n\n\nThis session will explore: \n\n\n\n\nThe key signals and criteria that indicate readiness for industrialisation\n\n\n\nCommon bottlenecks companies face when scaling from lab or pilot to full production\n\n\n\nFrameworks and options available to navigate this transition in a structured way\n\n\n\n\nWe’ll discuss with: \n\n\n\nRob Kooijmans (Food Safety) \n\n\n\nReza Ranjbar (AartinBio) \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/preparing-for-scale-industrial-readiness-and-infrastructure-access/
CATEGORIES:External,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/06/Event-Banners-Website-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260611T090000
DTEND;TZID=Europe/Brussels:20260611T133000
DTSTAMP:20260726T232931
CREATED:20260424T102431Z
LAST-MODIFIED:20260424T102433Z
UID:9607-1781168400-1781184600@www.europabio.org
SUMMARY:European Biotech Forum 2026
DESCRIPTION:EuropaBio is a proud sponsor of the European Biotech Forum 2026. \n\n\n\nBiotechnology is becoming a decisive capability for Europe’s competitiveness\, industrial resilience and strategic autonomy. But Europe enters the next institutional cycle with a fragmented policy landscape\, uneven regulatory capacity\, and persistent scale-up barriers. The Commission’s Biotech Communication I and Biotech Communication II set out an initial toolbox\, but fall short of an end-to-end industrial framework comparable to the US. The gap between ambition and execution remains significant. To what extent do these communications address the core challenges of Europe’s biotech sector? Where are the structural gaps that still block growth and industrial deployment? \n\n\n\n\nMore Info & Registration Here
URL:https://www.europabio.org/event/european-biotech-forum-2026/
CATEGORIES:EuropaBio,External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/04/Event-Banners-Website-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260610T080000
DTEND;TZID=Europe/Brussels:20260611T200000
DTSTAMP:20260726T232931
CREATED:20260216T122037Z
LAST-MODIFIED:20260422T072615Z
UID:9464-1781078400-1781208000@www.europabio.org
SUMMARY:Bio Innovations Europe 2026
DESCRIPTION:EuropaBio is joining Bio Innovations Europe 2026 as a Headline Partner. \n\n\n\nTaking place on 10-11 June 2026 in The Hague\, the event—formerly known as World Bio Markets—has seen exponential growth. Since its 2022 relaunch\, pre-arranged meetings have surged from 160 to over 1\,050 in 2025—a 550% increase. The 2026 edition is set to be the largest yet\, hosting more than 400 attendees and facilitating 1\,500 commercial meetings between bio-developers & producers\, chemical manufacturers\, consumer brands & intermediates\, community enablers\, investors & financiers and suppliers. \n\n\n\nDelivering the Biotech future of Europe: EuropaBio at Bio-Innovations \n\n\n\nEuropaBio\, the industry association that champions innovative bioindustries\, is proud to host a dedicated programme together with partner Bio-Innovations. \n\n\n\nEFIB presents Europe’s key opinion leaders\, bringing a clear statement to legislators at EU and national levels. 2026 brings legislation for simplification\, defragmentation and acceleration of biotechnology as a vital global technology and Europe must ensure that it can compete in the global race to dominance for biotechnology and biomanufacturing. \n\n\n\nIn addition to an opening keynote\, where the 2026 EFIB Statement will be launched\, EuropaBio\, through its EFIB platform\, will also host dedicated workshops: \n\n\n\nExecutive Round Table: Senior stakeholders from across the corporate\, policy and scientific community will discuss the priorities for Europe in 2026 and the ambition that must be delivered through legislative programmes that include the Bioeconomy Strategy\, Biotech Act and Food and Feed Safety Omnibus\, in addition to industrial policy levers including the European Competitiveness Fund\, EU Inc. and STEP regulation. \n\n\n\nSME Breakfast: The engine of innovation\, the SME breakfast will bring together the entrepreneurs that translate Europe’s research excellence into products\, delivering economic growth and supply chain resilience. The meeting will discuss their challenges and needs\, resulting in the 2026 SME Statement for Industrial Biotechnology\, published following the conference. \n\n\n\n25% discount for EuropaBio’s network: BIEUEB \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-innovations-europe-2026/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-37.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260506T080000
DTEND;TZID=Europe/Brussels:20260506T200000
DTSTAMP:20260726T232931
CREATED:20260219T124023Z
LAST-MODIFIED:20260219T124028Z
UID:9479-1778054400-1778097600@www.europabio.org
SUMMARY:BioPharmaChem Impact 2026
DESCRIPTION:BioPharmaChem 2026 will bring together leading business leaders and experts on many pertinent topics including: realising the potential of the ecosystem\, sustainability\, digitalisation\, the power of partnerships\, resilient supply chains\, the future of work\, EU competitiveness and more. \n\n\n\nDelegates will enjoy unmissable networking opportunities to connect with many biopharmaceuticals\, pharmaceuticals and chemicals professionals in our bespoke exhibition area. \n\n\n\nThe Awards Dinner will honour excellence in the BioPharmaChem sector and celebrate the remarkable contributions and innovations that are shaping the future of our industry. This will provide a fitting end to a truly engaging event. \n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/biopharmachem-impact-2026/
CATEGORIES:External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-41.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260429T080000
DTEND;TZID=Europe/Brussels:20260429T200000
DTSTAMP:20260726T232931
CREATED:20260219T123316Z
LAST-MODIFIED:20260219T123318Z
UID:9476-1777449600-1777492800@www.europabio.org
SUMMARY:Made by Cells - Biotech Forum
DESCRIPTION:Join our Director General Dr Claire Skentelbery in Finland! \n\n\n\nJoin us at the Hanaholmen Cultural Center in Espoo Finland for inspiring talks on Pharma & Diagnostics\, Food\, Pigments and Polymers\, alongside valuable networking opportunities with leading biotech innovators and stakeholders. Discover cutting-edge advancements and collaborate to shape the future of biotechnology. The event is organised in collaboration with VTT Technical Research Center of Finland \n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/made-by-cells-biotech-forum/
CATEGORIES:External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-40.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260422T080000
DTEND;TZID=Europe/Brussels:20260423T200000
DTSTAMP:20260726T232931
CREATED:20260304T091600Z
LAST-MODIFIED:20260304T091605Z
UID:9498-1776844800-1776974400@www.europabio.org
SUMMARY:CEBioForum 2026
DESCRIPTION:CEBioForum 2026 is a leading international biotechnology conference bringing together professionals from Central and Eastern Europe and beyond. With over 20 years of tradition\, CEBioForum serves as a trusted platform for dialogue\, partnership-building\, and knowledge exchange across the life sciences ecosystem. \n\n\n\nThe two-day event will take place in the modern spaces of CIC Warsaw\, located in the very center of the city\, and will feature a comprehensive program including high-level panel discussions\, keynote presentations\, startup pitch sessions\, an exhibition area\, and structured B2B networking supported by a dedicated event app. An evening networking reception and the CEBioForum Awards ceremony will further strengthen opportunities for meaningful connections. \n\n\n\nThe conference agenda will focus on the most relevant trends and challenges shaping the future of biotechnology and life sciences\, including biotech and pharma innovation\, medtech\, clinical trials\, data and AI in healthcare\, venture capital and financing in CEE\, cross-border collaboration\, dual-use technologies\, and pathways for scaling European innovations to global markets\, particularly the US. \n\n\n\nCEBioForum 2026 is the place to discover the dynamic Polish and CEE biotech ecosystem\, meet decision-makers\, investors\, entrepreneurs\, and researchers\, and explore opportunities for collaboration\, investment\, and growth in one of Europe’s fastest-developing life science regions. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/cebioforum-2026/
CATEGORIES:External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/03/Event-Banners-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260421T080000
DTEND;TZID=Europe/Brussels:20260421T200000
DTSTAMP:20260726T232931
CREATED:20260219T092703Z
LAST-MODIFIED:20260219T092708Z
UID:9473-1776758400-1776801600@www.europabio.org
SUMMARY:BioSolutions UK
DESCRIPTION:Proud to support BioSolutions UK conference — a new platform bringing together leaders in engineering biology to accelerate growth\, collaboration and real-world adoption. \n\n\n\nBiosolutions are reshaping food\, agriculture\, chemicals\, materials and biofuels\, and we’re excited to back an event championing the innovators driving this transition and strengthening the UK’s position in the global bioeconomy. \n\n\n\nJoin us on 21 April 2026 in London. \n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/biosolutions-uk/
CATEGORIES:External,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-39.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260414T143000
DTEND;TZID=Europe/Brussels:20260414T153000
DTSTAMP:20260726T232931
CREATED:20260309T135321Z
LAST-MODIFIED:20260309T143349Z
UID:9503-1776177000-1776180600@www.europabio.org
SUMMARY:The EU Biotech Act: Europe’s ambition for biotechnology
DESCRIPTION:Join Director General Sandra Gallina and EuropaBio to explore the EU Biotech Act proposal\, published in December 2025. \n\n\n\nThe webinar explores the Goal of the Act\, to boost innovation\, support development of biotech products and accelerate time-to-market\, making use of industrial enablers and regulatory simplification. \n\n\n\nThis webinar will introduce the drivers behind the Biotech Act proposal plus its diverse and ambitious mechanisms to boost EU biotech delivery. It will discuss how mechanisms might work and the interlink of the Act with the wider European Legislative landscape\, and its legislative pathway into action for the EU. \n\n\n\nWebinar delegates will have the opportunity to ask Director General Gallina questions during the event and EuropaBio will publish a summary for all participants. \n\n\n\nAGENDA \n\n\n\n\n\n\n\n\n14h30: Introduction – Dr Claire Skentelbery\, Director General EuropaBio \n\n\n\n\n\n\n\n\n\n14h40: The Biotech Act in focus – Director General Sandra Gallina\, DG Health and Food Safety\, European Commission: \n\n\n\n\n\nRegulatory streamlining and facilitation in health\, food and other biotech\n\n\n\nIndustrial enablers including High Impact Strategic Projects\, Boosting innovative biotech & biosimilars\, Access to Finance\, AI and Data\, Biosecurity & Defence\n\n\n\n\n15h10: Discussion and audience Q&A \n\n\n\n15h30: Close \n\n\n\nWho should attend? If you are active within biotechnology in any sector\, you should attend to understand what the Act means for you\, how you should be involved and what happens next. \n\n\n\nRegister below \n\n\n\n\nRegistration Here
URL:https://www.europabio.org/event/the-eu-biotech-act-europes-ambition-for-biotechnology/
CATEGORIES:Biomanufacturing Platform,EuropaBio,Healthcare Biotech,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/03/Event-Banners-Website-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260323T163000
DTEND;TZID=Europe/Brussels:20260323T180000
DTSTAMP:20260726T232931
CREATED:20260317T081056Z
LAST-MODIFIED:20260317T081058Z
UID:9523-1774283400-1774288800@www.europabio.org
SUMMARY:Special feature: Biotech Act Part I – Dr Claire Skentelbery\, Director General EuropaBio @ BIO-Europe Spring 2026
DESCRIPTION:Join our Director General Dr Claire Skentelbery at BIO-Europe Spring on the 23rd of March for an afternoon session dedicated to the EU Biotech Act Part 1. \n\n\n\nThe EU Biotech Act represents a landmark piece of legislation aimed at positioning Europe as a global leader in biotech. Structured in two parts\, the legislative program seeks to drive competitiveness across multiple sectors. Part I of the EU Biotech Act\, published in December 2025\, focuses on advancing health innovation. Key initiatives include accelerating clinical trials\, extending intellectual property protections\, launching a robust investment program\, and introducing strategic projects designed to achieve critical mass in applied innovation. Part II\, set to be unveiled in 2026\, will shift the focus toward maximising biomanufacturing across industries\, further strengthening Europe’s biotech ecosystem. \n\n\n\nThis feature session is dedicated to the Biotech Act part\, including a Keynote and Fireside Chat. \n\n\n\n16:30 Keynote presentation: Dr Claire Skentelbery\, Director General EuropaBio \n\n\n\n17:00 Fireside chat: Dr Claire Skentelbery in discussion with Dr Tilo Mandry\, Lead International Liaison Manager IGES \n\n\n\n17:15: Session: Special feature: Biotech Act Part I – What’s in it for me? Industry panel discussionPanelists:– Dr Morgane Rousselot\, Founder\, Chairwoman and CEO\, SeaBeLife Biotech– Dr Ann Belien\, Founder & CEO\, Rejuvenate Biomed (tbc)– Andreas Prenner\, Policy Officer\, European Commission– Dr Marjo Puumalainen\, International Director\, SwedenBIO– Dr Tilo Mandry\, Lead International Liaison Manager\, IGES (Moderator) \n\n\n\nThis panel continues the EU Biotech Act Special Feature: We will discuss what the Biotech Act means for biotech companies and Europe as a biotech investment location\, and how companies can best adapt to its provisions. \n\n\n\nThere are many questions about the Biotech Act:– How will industrial clinical research be accelerated and how will this affect the development of innovative therapies?– How will the Biotech Act impact the financing of innovative biotech start-ups?– Can cell and gene therapies now be developed more quickly by companies in the EU and brought to patients more easily?– What does the extension of intellectual property protection mean for biopharmaceutical companies in practice?– Is the Act sufficiently targeted at industry and where are the risk points?– And finally\, can the EU compete globally\, particularly with the US and China\, thanks to the Biotech Act?We will discuss these and many other important aspects with the panelists and the audience. \n\n\n\n18:00: Close \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/special-feature-biotech-act-part-i-dr-claire-skentelbery-director-general-europabio-bio-europe-spring-2026/
CATEGORIES:Biomanufacturing Platform,EuropaBio,External,Healthcare Biotech,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-38.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260323T080000
DTEND;TZID=Europe/Brussels:20260325T200000
DTSTAMP:20260726T232931
CREATED:20260219T090517Z
LAST-MODIFIED:20260219T090524Z
UID:9470-1774252800-1774468800@www.europabio.org
SUMMARY:BIO-Europe Spring 2026
DESCRIPTION:EuropaBio is joining BIO-Europe Spring 2026. \n\n\n\nBIO-Europe Spring is Europe’s largest springtime biotech partnering event\, bringing together over 3\,700 leaders and innovators in the life sciences industry. It’s designed for partnering\, business development\, and licensing opportunities in biotechnology and pharmaceuticals. \n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-europe-spring-2026/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-38.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20251124T080000
DTEND;TZID=Europe/Brussels:20251125T200000
DTSTAMP:20260726T232931
CREATED:20250618T133005Z
LAST-MODIFIED:20250618T133009Z
UID:9132-1763971200-1764100800@www.europabio.org
SUMMARY:Pitch Perfect and Boost the EU Bioeconomy 2025
DESCRIPTION:Pitching\, Matchmaking And Networking In The Heart Of Europe! \n\n\n\nThe ‘Pitch Perfect and Boost the European Bioeconomy’ event is a two day event of intense cross-border and cross-sectoral pitching\, matchmaking and networking\, with the aim to link industry to innovative (biobased) technologies\, innovators to investors and to create new partnerships for the future and the further development of innovative\, cross-border and cross-sectoral industrial value chains in the biobased economy. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/pitch-perfect-and-boost-the-eu-bioeconomy-2025/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/06/Event-Banners-Website-28.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20251015T120000
DTEND;TZID=Europe/Brussels:20251015T210000
DTSTAMP:20260726T232931
CREATED:20250505T110759Z
LAST-MODIFIED:20250814T132321Z
UID:9042-1760529600-1760562000@www.europabio.org
SUMMARY:Biotech & Biomanufacturing Policy Summit
DESCRIPTION:EuropaBio is pleased to host its third Summit focused on biotechnology & biomanufacturing. \n\n\n\nBiotechnology is a critical technology for Europe.  Delivery of innovation into market drives competitiveness\, security\, supply chain resilience plus societal and environmental goals.  Europe must be ambitious and globally aware\, with a focus on securing its biotechnology capability within fast changing global geopolitics. \n\n\n\nThe current Commission has a significant opportunity to set and deliver on the ambition needed. Legislation such as the Biotech Act\, plus the frameworks that we create for sectors including health\, agri-food and manufacturing. \n\n\n\nThe half day Summit brings together EuropaBio Members and stakeholders to understand the ambition needed for legislation\, how the EU and its Member States can deliver and recognition of global positioning needed. \n\n\n\nIt is supported by biotech product displays and EU projects\, plus evening networking reception. It will be followed by a Summit Statement and public webinar hosted in November. \n\n\n\nAgenda: \n\n\n\n12:30 Registration and lunch13:15 Welcome and Keynote session Summit keynotes bring Industry\, Parliament and Commission perspectives to Europe’s ambition for biotech and biomanufacturing and the policy framework currently in action. Commissioner Olivér Várhelyi – Commissioner for Health and Animal Welfare Markus Staempfli – EuropaBio Chair\, Vice President Europe Major Markets & Canada\, CSL Behring MEP Stine Bosse – MEP and co-chair EU Alliance of Biotech and Life Sciences14:00 Panel sessions The current legislative cluster impacting biotechnology and biomanufacturing is in focus for our panel discussions. Stakeholders from across industry\, policy and member states discuss what Europe’s ambition must be and how individual and aligned legislations can deliver.Panel 1 – Enabling EU markets How policy creates markets for biotech products and enables biomanufacturing processes.Panel 2 – Enhancing access How market pathways are vital for product and process commercial viability\, determining speed and scale of access and uptake.Panel 3 – Building the EU ecosystem How knowledge\, skills\, finance and infrastructure deliver on market potential for Europe.17:50 Pre-reception remarks18:00 Reception20:30 Close\n\n\n\nThis event will be accessible by invitation only\, for more information contact us at: communications@europabio.org and c.skentelbery@europabio.org
URL:https://www.europabio.org/event/biotech-biomanufacturing-policy-summit/
CATEGORIES:Biomanufacturing Platform,EuropaBio,Healthcare Biotech,Industrial Biotech,National Associations,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/05/Event-Banner-Website-Biotech-Biomanufacturing-Policy-Summit.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250917T080000
DTEND;TZID=Europe/Brussels:20250918T200000
DTSTAMP:20260726T232931
CREATED:20250618T121730Z
LAST-MODIFIED:20250618T121731Z
UID:9127-1758096000-1758225600@www.europabio.org
SUMMARY:Life Sciences Baltics 2025
DESCRIPTION:Join our Director General Claire Skentelbery at the Life Sciences Baltics 2025 conference where she will be speaking on The EU Biotech Act – leading Europe’s evolution and revolution for competitiveness. \n\n\n\nLife Sciences Baltics is the leading event in the Baltic region\, connecting global life sciences professionals. This event provides unique opportunities for project initiation\, lead generation\, and strategic partnerships through an extensive exhibitor showcase\, insightful conferences\, a dedicated partnering area\, diverse networking formats\, and competitions\, including a startup pitch challenge. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/life-sciences-baltics-2025/
CATEGORIES:External,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/06/Event-Banners-Website-27.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250612T133000
DTEND;TZID=Europe/Brussels:20250612T143000
DTSTAMP:20260726T232931
CREATED:20250428T070156Z
LAST-MODIFIED:20250505T082148Z
UID:9012-1749735000-1749738600@www.europabio.org
SUMMARY:EFIB Brussels Statement – a competitive future for the EU
DESCRIPTION:The EFIB Brussels statement was published following the successful workshop that EuropaBio organised together with Genopole during the Bioket conference on 11 March. It looks ahead to the decisions that the EU must now take through the policies and initiatives currently in process. A key opportunity exists for societal and industrial transformation within the sustainability and safety ambitions that make Europe a global figurehead. \n\n\n\nThe agenda of the EFIB webinar 2025 is as follows: \n\n\n\n\nPresentation of the EFIB statement by our Director General\, Claire Skentelbery.\n\n\n\nPanel discussion with our wonderful participants.\n\n\n\nConfirmed Speakers\n\nMaarit Nyman – Senior Expert on Industrial Bioeconomy\, European Commission\n\n\n\nAna Maria Bravo – Director of Government Affairs\, IFF\n\n\n\nSaskia Kliphuis-Schotsman – Public Affairs Manager\, Corbion\n\n\n\nMonica Christensen – Senior Public Affairs Manager\, Novonesis\n\n\n\n\n\n\nThis will be followed by a short Q&A session. \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/efib-brussels-statement-a-competitive-future-for-the-eu/
CATEGORIES:EFIB,EuropaBio,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/04/Event-Banners-Website-19.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250507T000000
DTEND;TZID=Europe/Brussels:20250508T235959
DTSTAMP:20260726T232931
CREATED:20250303T145152Z
LAST-MODIFIED:20250303T145236Z
UID:8834-1746576000-1746748799@www.europabio.org
SUMMARY:Knowledge for Growth 2025
DESCRIPTION:Mark your calendar for Knowledge for Growth 2025\, Europe’s premier life sciences conference\, taking place on 8 May 2025 in the dynamic city of Antwerp\, Belgium! \n\n\n\nConnect with over 1\,000 life sciences professionals from 500+ companies and organisations\, including decision-makers from biotech\, pharma\, MedTech\, AgTech\, and healthtech\, as well as investors\, universities\, research institutes\, policymakers\, and service providers. \n\n\n\nImmerse yourself in an action-packed programme offering exclusive insights into the global and regional life sciences landscape\, one-to-one partnering\, a vibrant trade fair\, and countless networking opportunities. \n\n\n\nDon’t miss the chance to elevate your knowledge and expand your network at Knowledge for Growth 2025! \n\n\n\nUSE CODE: KFG2025CLUSTER15 FOR A 15% DISCOUNT \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/knowledge-for-growth-2025/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/03/Event-Banners-Website-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250228T090000
DTEND;TZID=Europe/Brussels:20250228T103000
DTSTAMP:20260726T232931
CREATED:20250211T094956Z
LAST-MODIFIED:20250211T094957Z
UID:8724-1740733200-1740738600@www.europabio.org
SUMMARY:B-Trust’s 2nd  masterclass: Co-Creating Trust in Biotech – Cell Factories
DESCRIPTION:How can biotechnology help shape a more sustainable food system? While scientific advancements are creating greener and more innovative ingredients\, gaining consumer trust remains a key challenge.In this exclusive online masterclass\, we’ll explore the role of cell factories – microorganisms that produce specialty food ingredients through fermentation – and their potential to revolutionise food production while reducing land use\, water consumption\, and carbon emissions. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/b-trusts-2nd-masterclass-co-creating-trust-in-biotech-cell-factories/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2025/02/Event-Banners-Website-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250129T183000
DTEND;TZID=Europe/Brussels:20250129T203000
DTSTAMP:20260726T232931
CREATED:20241217T125548Z
LAST-MODIFIED:20250128T102313Z
UID:8543-1738175400-1738182600@www.europabio.org
SUMMARY:A Driver of European Competitiveness: The Future of European Biotech
DESCRIPTION:EuropaBio\, the European association representing Bioindustries\, will host an evening reception co-hosted by MEP Stine Bosse (Vice-Chair\, SANT) and MEP Eszter Lakos (Member\, ITRE)\, to discuss the role of the European biotech sector in making the European industry more competitive. \n\n\n\nAmbassador Søren Jacobsen\, Deputy Permanent Representative of Denmark to the EU\, and Kristin Schreiber\, Director at DG GROW\, Klaus Berend\, Director SANTE will share some remarks on their approach to the biotech sector in the new mandate. \n\n\n\nThis event is only open to EuropaBio members & invited guests\, to find out more about EuropaBio membership\, contact us through our website here.
URL:https://www.europabio.org/event/a-driver-of-european-competitiveness-the-future-of-european-biotech/
CATEGORIES:Biomanufacturing Platform,EuropaBio,Healthcare Biotech,Industrial Biotech,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/12/EUROPABIO.6788f179502696.54888785.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241112T090000
DTEND;TZID=Europe/Brussels:20241112T123000
DTSTAMP:20260726T232931
CREATED:20241029T085347Z
LAST-MODIFIED:20241029T085348Z
UID:8437-1731402000-1731414600@www.europabio.org
SUMMARY:Advancing bio-based innovations in the food industry: Focus on fermentation
DESCRIPTION:Join our Director General Dr Claire Skentelbery on the 12th of November in Brussels where she will be speaking at the DG GROW hosted hybrid workshop “Advancing bio-based innovations in the food industry: Focus on fermentation”. \n\n\n\nThe workshop will focus on the industrial applications of fermentation technologies by highlighting SMEs that are using biomass\, precision and gas fermentation. Their innovative technologies will be presented\, along with ways to promote scaling up production. These presentations will be followed by a Q&A session. \n\n\n\nAfter these industry insights\, a panel of experts will discuss topics such as research and innovation\, infrastructure\, the role of farmers\, public acceptance\, market development\, and profitability and pricing. In addition to the fermentation types presented at the beginning of the workshop\, micro fermentation will be discussed. \n\n\n\nDeadline for registrations: 4 November 2024 \n\n\n\n\nMore Information & Register Here
URL:https://www.europabio.org/event/advancing-bio-based-innovations-in-the-food-industry-focus-on-fermentation/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/External-Events-Banners-600-×-200px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241023T080000
DTEND;TZID=Europe/Brussels:20241024T200000
DTSTAMP:20260726T232931
CREATED:20241003T082016Z
LAST-MODIFIED:20241003T082123Z
UID:8368-1729670400-1729800000@www.europabio.org
SUMMARY:Regulating the Future of Food Conference
DESCRIPTION:Join our Industrial Biotechnology Senior Manager Lucie McMurtry on the 23rd and 24th of October in Amsterdam where she will be speaking at the Regulating the Future of Food Conference. \n\n\n\nGlobal innovation in food-tech is growing at an incredible pace and there are so many amazing new products and processes out there! This innovation is vital in making a difference to the planet by creating more sustainable and ‘greener’ food systems\, whilst also contributing to economic growth. \n\n\n\nRegulators are doing their best to keep up. They are all working on ways to evolve in line with innovation and create more effective and efficient ways to regulate novel foods\, whilst keeping safety as the key priority. However\, regulations are often seen as a barrier to innovation due to complex frameworks\, a lack of clear guidance and long evaluation timelines. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/regulating-the-future-of-food-conference/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/Healthcare-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241008T100000
DTEND;TZID=Europe/Brussels:20241010T180000
DTSTAMP:20260726T232931
CREATED:20240828T135105Z
LAST-MODIFIED:20240828T135930Z
UID:8158-1728381600-1728583200@www.europabio.org
SUMMARY:CPHI Milan
DESCRIPTION:EuropaBio is pleased to partner with CPHI Milan 2024\, the biggest international pharmaceutical industry event for the thirty fifth anniversary edition. This year’s edition held from the 8th to the 10th of October in Fiera Milano\, Italy promises to a packed agenda with over 150 expert international speakers with over 100 content sessions. \n\n\n\nJoin our Director General Dr Claire Skentelbery this year where she will be speaking on the 9th of October to discuss how cultivated meat has the potential to revolutionise biologic manufacturing. Join her in Hall 3 – 3F97 at 16:15 on 09/10/2024 to find out more. \n\n\n\n \n\n\n\n\nFind Out More & Register Here
URL:https://www.europabio.org/event/cphi-milan/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/08/CPHI-x-EuropaBio-2024-Event-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240710T080000
DTEND;TZID=Europe/Brussels:20240711T170000
DTSTAMP:20260726T232931
CREATED:20240531T135225Z
LAST-MODIFIED:20240531T135227Z
UID:7893-1720598400-1720717200@www.europabio.org
SUMMARY:CURIOUS­ FUTURE INSIGHT™ CONFERENCE
DESCRIPTION:Over the millennia science & technology have steadily advanced\, but key unsolved challenges remain\, and much more is possible. The Curious – Future Insight™ Conference brings together some of the world’s brightest scientists and most accomplished innovators to present their work and explore the future of science and technology\, solving the challenges of today and enabling the dreams of a better tomorrow. \n\n\n\nThe Curious – Future Insight™ conference featurestop speakers and Nobel laureates from all over theworld\, among them: \n\n\n\n\nEmmanuelle Charpentier\, MPI (2018)\n\n\n\nSteven Chu\, Stanford University (2024)\n\n\n\nRobert Langer\, MIT (2024)\n\n\n\nSatya Nadella\, CEO Microsoft (2018)\n\n\n\nUğur Şahin\, CEO BioNTech (2024)\n\n\n\nRandy Schekman\, Berkeley (2024)\n\n\n\nThomas C. Südhof\, Stanford University (2024\, 2022)\n\n\n\nCraig Venter\, Craig Venter Institute (2018)
URL:https://www.europabio.org/event/curious-future-insight-conference/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/05/Curious-Insights-Banner-600-×-200px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240319T143000
DTEND;TZID=Europe/Brussels:20240319T164500
DTSTAMP:20260726T232931
CREATED:20240213T092326Z
LAST-MODIFIED:20240213T093923Z
UID:7402-1710858600-1710866700@www.europabio.org
SUMMARY:Industrial biotech: Is Europe ready to harness its potential?
DESCRIPTION:A Science | Business closed-door roundtable\, organised in partnership with EuropaBio – followed by networking reception \n\n\n\nOnly By Invitation \n\n\n\n \n\n\nBackground Information \nIn recent years industrial biotechnology – also known as “white” biotech – has emerged as a high-value driver of industrial modernisation and the green transition. Through the innovative use of microorganisms and enzymes\, it has transformative potential for manufacturing\, waste use and the creation of sustainable products in sectors as varied as energy\, textiles\, plastics\, paper\, agriculture and water. While some core processes\, such as fermentation technology\, have been commercially deployed for around 50 years\, the speed of scientific progress and solution development are accelerating exponentially. As such\, it appears that the sector as a whole is truly poised to make the leap from “proof of concept” to mainstream application at the European level.  \nThese take on greater importance when one considers other strategic priorities for the EU. First\, it is clear that for Europe to achieve e.g. its 2030 benchmark for net-zero technology manufacturing in the Green Deal Industrial Plan (GDIP)\, it will need to leverage its full innovation capacity across sectors. Second\, as global demand grows for sustainable solutions to climate\, energy\, biodiversity and food system crises\, Europe is ideally positioned to take market leadership in various domains\, given its research excellence and strong industrial base. And third\, the EU’s proposed Strategic Technologies for Europe Platform (STEP) has already identified biotechnologies among its key value chains to ensure future resilience\, autonomy and competitiveness\, while biotechnology has also been recognised as a critical technology for Europe. \nYet a degree of skepticism remains – both in public and policy circles – about the risk/reward ratio of biotechnologies and their wider value to society. One useful counterpoint is to consider the evolution of health-related biotechnology (often called “red” biotech). Having overcome similar resistance and concerns\, “red” biotech is now deployed at scale throughout the life science and pharmaceutical sectors\, and is acknowledged today as a key component in European health innovation. So how can the lessons learned on that journey be absorbed and applied to other sectors?   \n As the EU prepares for its transition to a new Parliament and Commission\, it is therefore an ideal moment to open a multistakeholder dialogue on how policy and regulatory innovations could increase the European added value of “white” biotech and biomanufacturing in the years to come. This also builds on Ursula von der Leyen’s announcement of a new biotech and biomanufacturing initiative in last September’s state-of-the-union address. Among some of the key issues for consideration: \nWhere can industrial biotech and biomanufacturing contribute most effectively to the GDIP and STEP\, and what are the longer-term implications for boosting the global competitiveness of European companies?\nWhat should underpin a future EU roadmap for advancing “white” biotech and biomanufacturing across sectors\, in line with other long-term strategies and objectives?\nWhich other steps are needed at EU and national level to build future capacity\, such as infrastructure and skills?\nIn which ways can public and private finance best support pioneering “white” biotech firms – large and small – in scaling up and maturing their solutions to market-readiness and mass production levels\, as has happened in the health sector?\nBeyond the CBE Joint Undertaking\, to what extent could Horizon Europe\, FP10 and other key instruments – such as the new biotech & biomanufacturing initiative – strengthen Europe’s industrial biotech R&D ecosystem in the next policy cycle?\nOn March 19\, Science|Business\, in cooperation with EuropaBio\, will convene a select group of senior figures and experts from across the industrial biotech spectrum to address these issues in a closed-door\, invitation-only roundtable. Drawing in part on latest research and real-world applications\, the meeting will identify recommendations to harness the full potential of “white” biotech and biomanufacturing\, and to align its further development with the realisation of key EU policy goals.\n \n \n\n\n\n\n\n\n \n\n\n\n \n\n\n\nFor more information\, please contact: denitsa.nikolova@sciencebusiness.ne \n\n\n\n \n\n\n\n \n\n\n\n\nClick here for more information
URL:https://www.europabio.org/event/industrial-biotech-is-europe-ready-to-harness-its-potential/
CATEGORIES:EuropaBio,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/02/Event-Banners-Website-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20231201T083000
DTEND;TZID=Europe/Brussels:20231201T094500
DTSTAMP:20260726T232931
CREATED:20231031T084455Z
LAST-MODIFIED:20231031T084520Z
UID:7041-1701419400-1701423900@www.europabio.org
SUMMARY:EFIB 2023 Rotterdam Statement wider launch
DESCRIPTION:Industrial biotechnology for a sustainable and resilient global Europe  \n\n\n\nAs the EU looks ahead to the European elections in 2024\, with a new EU Commission mandate and Work Programme\, EuropaBio reviews European strategies and ambitions where biotechnology plays a key role. Ursula von der Leyen’s State of the European Union address of 13 September announced an ‘EU Biotech and Biomanufacturing Initiative’. The announced EU initiative is the latest indication of a greater point of recognition and acceleration for biotechnology. \n\n\n\nBuilding on this momentum\, the EFIB Rotterdam Statement of 2023 provides a priority pathway for biotechnology to support Europe’s global leadership\, resilience and competitiveness. \n\n\n\nWe invite you to join us for a discussion on the role and potential of biotechnology and Europe’s global position in the context of the 2024 EU election. \n\n\n\n\nInvitation Only Event
URL:https://www.europabio.org/event/efib-2023-rotterdam-statement-wider-launch/
CATEGORIES:EFIB,EuropaBio,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/10/Vilnius-Statement-Event-600-×-260px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230929T100000
DTEND;TZID=Europe/Brussels:20230930T190000
DTSTAMP:20260726T232931
CREATED:20230320T153927Z
LAST-MODIFIED:20230320T160626Z
UID:6049-1695981600-1696100400@www.europabio.org
SUMMARY:International Forum on Industrial Biotechnology and Bioeconomy (IFIB)
DESCRIPTION:NETWORKING AND PARTNERSHIPS IN BIOECONOMY AREA \n\n\n\nIFIB – International Forum on Industrial Biotechnology and Bioeconomy aims at strengthening the bioeconomy network in the Euro-Mediterranean area and to promote partnerships. The focus of the Forum is biotechnology\, as provider of new resources for industries. \n\n\n\nIt is organized into round-tables and sessions devoted to specific sub-sectors of industrial biotechnology: bio-based industries\, agro-food\, energy\, environment policies on industrial biotech and bioeconomy\, involving international speakers coming from key sector’s players. \n\n\n\nEdition 2023 > 29/30 September Bari \n\n\n\n\nMore information
URL:https://www.europabio.org/event/international-forum-on-industrial-biotechnology-and-bioeconomy-ifib/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230926T100000
DTEND;TZID=Europe/Brussels:20230928T190000
DTSTAMP:20260726T232931
CREATED:20230320T145053Z
LAST-MODIFIED:20230320T145327Z
UID:6038-1695722400-1695927600@www.europabio.org
SUMMARY:BIOSPAIN 2023
DESCRIPTION:BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 34% of our delegates came from outside of Spain. \n\n\n\nThis year\, BIOSPAIN goes back to Barcelona\, the main biotech cluster in Spain and one of the most dynamic cities in the world. \n\n\n\nThe event will take place in Pavilion 1 – Fira de Barcelona – Montjuïc. It stands in a superb location in the city center\, easily accessible from the airport and well-connected to the public transport network. It is located in Montjuïc Park\, an area of cultural and historical interest thanks to its museums and theatres and it also features some of the main tourist attractions in Barcelona. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/biospain-2023/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230630T124500
DTEND;TZID=Europe/Brussels:20230630T124500
DTSTAMP:20260726T232931
CREATED:20230321T210403Z
LAST-MODIFIED:20230321T210405Z
UID:6074-1688129100-1688129100@www.europabio.org
SUMMARY:DUTCH BIOTECH EVENT 2023
DESCRIPTION:Join us to celebrate the power of biotech at the Dutch Biotech Event 2023! \n\n\n\nAbout HollandBIO’s Dutch Biotech Event \n\n\n\nThe program features inspiring talks by keynote speakers on biotech and entrepreneurship\, followed by workshops and break-out sessions that contribute to your personal development and that of your company. In addition\, there will be plenty of opportunities for networking during the break\, drinks and vegetarian BBQ. \n\n\n\nWho can join Dutch Biotech Event? \n\n\n\nThe Dutch Biotech Event welcomes HollandBIO members (registration free of charge) and employees of other biotech R&D companies (registration fee €295\,- p.p.)\, with a maximum of 2 delegates per organization. \n\n\n\nWe invite non-member startups to consider a HollandBIO membership (€562\,-/year)\, which besides access to the network & events\, offers many more advantages. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/dutch-biotech-event-2023/
LOCATION:Inn Style\, Herenweg 55\, Maarssen\, 3602 AN\, Netherlands
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230601T100000
DTEND;TZID=Europe/Brussels:20230601T190000
DTSTAMP:20260726T232931
CREATED:20230321T205822Z
LAST-MODIFIED:20230321T210149Z
UID:6071-1685613600-1685646000@www.europabio.org
SUMMARY:KNOWLEDGE FOR GROWTH 2023
DESCRIPTION:Knowledge for Growth is Europe’s finest life sciences conference.For the first time the event will take place in Antwerp.\n\n\n\nThe conference features an exciting programme providing vital insight into the global life sciences’ landscape\, one-to-one partnering\, a trade fair and more! \n\n\n\nLEARN. CONNECT. DISCOVER.\n\n\n\nThe cream of the Belgian life sciences community attends flanders.bio’s annual Knowledge for Growth business conference\, attracting decision makers from biotech\, pharma and medtech\, agricultural and chemical industry as well as investors\, universities\, top-notch research institutes\, policymakers and competence providers. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/knowledge-for-growth-2023/
LOCATION:Flanders Meeting & Convention Center Antwerp\, Koningin Astridplein 26\, Antwerp\, 2018\, Belgium
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-5.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230424T100000
DTEND;TZID=Europe/Brussels:20230425T190000
DTSTAMP:20260726T232931
CREATED:20230111T144716Z
LAST-MODIFIED:20230111T144717Z
UID:5648-1682330400-1682449200@www.europabio.org
SUMMARY:Swiss Biotech Day 2023
DESCRIPTION:The Swiss Biotech Day has become one of the leading biotechnology conferences in Europe and a fixed date in the community’s calendar. In 2022\, the conference demonstrated the impressive growth of the Swiss biotech industry and presented an exciting program with ideal networking opportunities for over 1\,100 participants across the globe. \n\n\n\nIn 2023\, the Swiss Biotech Day will again offer high-level experts from the life science industry the space to network\, discuss and discover trends in R&D\, manufacturing\, data management\, artificial intelligence and innovative financing over one and a half days. In addition\, international biotech delegations can take part in the “Global Village” to strengthen their ties with Switzerland as a biotech hub and promote cross-border investments\, public-private partnerships\, research and development collaborations and exchange of talent.  \n\n\n\nWe hope to see you in Basel on April 24-25\, 2023 in person again. \n\n\n\nWhat to expect: \n\n\n\n\nMeet 1.000+ senior experts from the life science industry\n\n\n\n70+ exhibitors and global village with international delegations from all over the world\n\n\n\nSwiss Biotech Success Stories Awards\n\n\n\nInnovative biotech start-ups and medium-sized biotech companies\n\n\n\nThematically focused panel discussions\n\n\n\nSwiss Biotech Report 2023\n\n\n\nPre-scheduled one-to-one partnering meetings\n\n\n\nGeneral Assembly of the Swiss Biotech Association\n\n\n\n\n\nMore information
URL:https://www.europabio.org/event/swiss-biotech-day-2023/
LOCATION:Congress Center Basel\, Messeplatz 21\, Basel\, 4058\, Switzerland
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/01/Biomanufacturing-Policy-Summit-2023-2.png
END:VEVENT
END:VCALENDAR